InfuSystem Holdings (INFU) EBT Margin Growth (1y) (2011 - 2026)
InfuSystem Holdings (INFU) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn | -287.00 |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | -464.00 |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn | 772.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 233.00 |
| 10 | InfuSystem Holdings | 189.28 Mn | 187.17 Mn | 19.68 Mn | 334.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 334.00 |
| Dec 31, 2025 | 305.00 |
| Sep 30, 2025 | 151.00 |
| Jun 30, 2025 | 559.00 |
| Mar 31, 2025 | 492.00 |
| Dec 31, 2024 | 431.00 |
| Sep 30, 2024 | 438.00 |
| Jun 30, 2024 | 187.00 |
| Mar 31, 2024 | -208.00 |
| Dec 31, 2023 | 46.00 |
| Sep 30, 2023 | 150.00 |
| Jun 30, 2023 | 249.00 |
| Mar 31, 2023 | 113.00 |
| Dec 31, 2022 | -223.00 |
| Sep 30, 2022 | 451.00 |
| Jun 30, 2022 | -188.00 |
| Mar 31, 2022 | -507.00 |
| Dec 31, 2021 | 94.00 |
| Sep 30, 2021 | -1,436.00 |
| Jun 30, 2021 | -1,464.00 |